检索结果 - Jinender Kumar

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma

    Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicula... 由 Loretta J. Nastoupil, Ashley Bonner, Pearl Wang, Lamees Almuallem, Jigar Desai, Thalia A. Farazi, Jinender Kumar, Saurabh Dahiya

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

    Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study 由 Franck Morschhauser, Saurabh Dahiya, M. Lia Palomba, Alejandro Martı́n, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad S. Kahl, Hervé Ghesquières, Kirit M. Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S. Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan P Skarbnik, Sven de Vos, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia A. Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Jinender Kumar, Loretta J. Nastoupil

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: